Aberdeen Wealth Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,180
Closed -$206K 171
2021
Q4
$206K Buy
+1,180
New +$197K 0.13% 140
2021
Q3
Sell
-1,180
Closed -$212K 123
2021
Q2
$212K Hold
1,180
0.2% 122
2021
Q1
$228K Sell
1,180
-10
-0.8% -$1.93K 0.18% 128
2020
Q4
$240K Sell
1,190
-121
-9% -$25K 0.18% 123
2020
Q3
$276K Sell
1,311
-92
-7% -$20.5K 0.26% 106
2020
Q2
$308K Buy
1,403
+93
+7% +$18.6K 0.33% 91
2020
Q1
$227K Buy
1,310
+1
+0.1% +$165 0.28% 103
2019
Q4
$201K Buy
+1,309
New +$196K 0.15% 133

Other funds holding CLX

Aberdeen Wealth Management's CLX Position: Q1 2022 in Review

Aberdeen Wealth Management sold out of Clorox (CLX) in Q1 2022, closing a stake of 1,180 shares — an estimated $206K sold.

Aberdeen Wealth Management first reported a position in CLX in Q4 2019 and held it in 8 quarters. The position peaked at $308K in Q2 2020. 1,095 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

  • Aberdeen Wealth Management reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
  • Aberdeen Wealth Management sold 1,180 Clorox shares in Q1 2022, an estimated $206K.
  • Aberdeen Wealth Management first reported a position in Clorox in Q4 2019 and held it in 8 quarters.
  • Aberdeen Wealth Management's Clorox position peaked at $308K in Q2 2020.
  • 1,095 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Aberdeen Wealth Management's 13F filing for Q1 2022, filed 12 May 2022.